Retinoids Activate the Irritant Receptor TRPV1 and Produce Sensory Hypersensitivity

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2013 Aug 9

PMID 23925292

Citations 30

Authors

Shijin Yin

Jialie Luo

Aihua Qian

Junhui Du

Qing Yang

Shentai Zhou

Weihua Yu

Guangwei Du

Richard B Clark

Edgar T Walters

Susan M Carlton

Hongzhen Hu

Affiliations

Soon will be listed here.

Abstract

Retinoids are structurally related derivatives of vitamin A and are required for normal vision as well as cell proliferation and differentiation. Clinically, retinoids are effective in treating many skin disorders and cancers. Application of retinoids evokes substantial irritating side effects, including pain and inflammation; however, the precise mechanisms accounting for the sensory hypersensitivity are not understood. Here we show that both naturally occurring and synthetic retinoids activate recombinant or native transient receptor potential channel vanilloid subtype 1 (TRPV1), an irritant receptor for capsaicin, the pungent ingredient of chili peppers. In vivo, retinoids produced pain-related behaviors that were either eliminated or significantly reduced by genetic or pharmacological inhibition of TRPV1 function. These findings identify TRPV1 as an ionotropic receptor for retinoids and provide cellular and molecular insights into retinoid-evoked hypersensitivity. These findings also suggest that selective TRPV1 antagonists are potential therapeutic drugs for treating retinoid-induced sensory hypersensitivity.

Citing Articles

Silybum marianum Extract: A Highly Effective Natural Alternative to Retinoids to Prevent Skin Aging Without Side Effects.

Boira C, Chapuis E, Lapierre L, Tiguemounine J, Scandolera A, Reynaud R J Cosmet Dermatol. 2024; 24(1):e16613.

PMID: 39692756 PMC: 11743331. DOI: 10.1111/jocd.16613.

Palmitoylation by ZDHHC4 inhibits TRPV1-mediated nociception.

Zhang Y, Zhang M, Tang C, Hu J, Cheng X, Li Y EMBO Rep. 2024; 26(1):101-121.

PMID: 39528731 PMC: 11724110. DOI: 10.1038/s44319-024-00317-0.

Nociceptive transient receptor potential ankyrin 1 (TRPA1) in sensory neurons are targets of the antifungal drug econazole.

Kasuya K, Takahashi K, Hashimoto M, Ohta T BMC Pharmacol Toxicol. 2024; 25(1):53.

PMID: 39169383 PMC: 11337588. DOI: 10.1186/s40360-024-00779-x.

Vitamin A resolves lineage plasticity to orchestrate stem cell lineage choices.

Tierney M, Polak L, Yang Y, Abdusselamoglu M, Baek I, Stewart K Science. 2024; 383(6687):eadi7342.

PMID: 38452090 PMC: 11177320. DOI: 10.1126/science.adi7342.

Improvement of mild photoaged facial skin in middle-aged Chinese females by a supramolecular retinol plus acetyl hexapeptide-1 containing essence.

Ye Y, Li Y, Xu C, Wei X Skin Health Dis. 2023; 3(4):e239.

PMID: 37538317 PMC: 10395635. DOI: 10.1002/ski2.239.

References

Hsu P, Litman G, Brodell R . Overview of the treatment of acne vulgaris with topical retinoids. Postgrad Med. 2011; 123(3):153-61. DOI: 10.3810/pgm.2011.05.2294. View

Villablanca J, London W, Naranjo A, McGrady P, Ames M, Reid J . Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group. Clin Cancer Res. 2011; 17(21):6858-66. PMC: 3207022. DOI: 10.1158/1078-0432.CCR-11-0995. View

Alique M, Lucio F, Herrero J . Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. II. Effects after intrathecal administration. Br J Pharmacol. 2006; 149(1):65-72. PMC: 1629404. DOI: 10.1038/sj.bjp.0706826. View

Hardie R . TRP channels and lipids: from Drosophila to mammalian physiology. J Physiol. 2006; 578(Pt 1):9-24. PMC: 2075119. DOI: 10.1113/jphysiol.2006.118372. View

Caterina M, Leffler A, Malmberg A, Martin W, Trafton J, Koltzenburg M . Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000; 288(5464):306-13. DOI: 10.1126/science.288.5464.306. View

Bedi S, Yang Q, Crook R, Du J, Wu Z, Fishman H . Chronic spontaneous activity generated in the somata of primary nociceptors is associated with pain-related behavior after spinal cord injury. J Neurosci. 2010; 30(44):14870-82. PMC: 3073589. DOI: 10.1523/JNEUROSCI.2428-10.2010. View

Pecze L, Szabo K, Szell M, Josvay K, Kaszas K, Kusz E . Human keratinocytes are vanilloid resistant. PLoS One. 2008; 3(10):e3419. PMC: 2566593. DOI: 10.1371/journal.pone.0003419. View

Toth B, Geczy T, Griger Z, Dozsa A, Seltmann H, Kovacs L . Transient receptor potential vanilloid-1 signaling as a regulator of human sebocyte biology. J Invest Dermatol. 2008; 129(2):329-39. DOI: 10.1038/jid.2008.258. View

Planells-Cases R, Garcia-Sanz N, Morenilla-Palao C, Ferrer-Montiel A . Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia. Pflugers Arch. 2005; 451(1):151-9. DOI: 10.1007/s00424-005-1423-5. View

10.

Gavva N, Treanor J, Garami A, Fang L, Surapaneni S, Akrami A . Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain. 2008; 136(1-2):202-10. DOI: 10.1016/j.pain.2008.01.024. View

11.

Hillery C, Kerstein P, Vilceanu D, Barabas M, Retherford D, Brandow A . Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease. Blood. 2011; 118(12):3376-83. PMC: 3179403. DOI: 10.1182/blood-2010-12-327429. View

12.

Zygmunt P, Petersson J, Andersson D, Chuang H, Sorgard M, Di Marzo V . Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999; 400(6743):452-7. DOI: 10.1038/22761. View

13.

Geria A, Lawson C, Halder R . Topical retinoids for pigmented skin. J Drugs Dermatol. 2011; 10(5):483-9. View

14.

Patapoutian A, Tate S, Woolf C . Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov. 2009; 8(1):55-68. PMC: 2755576. DOI: 10.1038/nrd2757. View

15.

Pehlivan Y, Kisacik B, Sayiner Z, Onat A . Inflammatory back pain in patients treated with isotretinoin. J Rheumatol. 2011; 38(12):2690. DOI: 10.3899/jrheum.110703. View

16.

Mukherjee S, Date A, Patravale V, Korting H, Roeder A, Weindl G . Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2007; 1(4):327-48. PMC: 2699641. DOI: 10.2147/ciia.2006.1.4.327. View

17.

Devaux Y, Seguin C, Grosjean S, de Talance N, Schwartz M, Burlet A . Retinoic acid and lipopolysaccharide act synergistically to increase prostanoid concentrations in rats in vivo. J Nutr. 2001; 131(10):2628-35. DOI: 10.1093/jn/131.10.2628. View

18.

Engel M, Leffler A, Niedermirtl F, Babes A, Zimmermann K, Filipovic M . TRPA1 and substance P mediate colitis in mice. Gastroenterology. 2011; 141(4):1346-58. DOI: 10.1053/j.gastro.2011.07.002. View

19.

Jara-Oseguera A, Simon S, Rosenbaum T . TRPV1: on the road to pain relief. Curr Mol Pharmacol. 2009; 1(3):255-69. PMC: 2802457. DOI: 10.2174/1874467210801030255. View

20.

Webster G, Berson D, Stein L, Fivenson D, Tanghetti E, Ling M . Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial. Cutis. 2001; 67(6 Suppl):4-9. View